Efficacy and safety of Bacteroides fragilis BF839 for pediatric autism spectrum disorder: a randomized clinical trial

BackgroundThe clinical utility of Bacteroides fragilis in treating autism spectrum disorder (ASD) remains unclear. Therefore, this randomized, double-blind, placebo-controlled study aimed to explore the therapeutic effects and safety of B. fragilis BF839 in the treatment of pediatric ASD.MethodsWe e...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Chu-hui Lin, Ting Zeng, Cui-wei Lu, De-yang Li, Yi-ying Liu, Bing-mei Li, Sheng-qiang Chen, Yu-hong Deng
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2024-09-01
Serija:	Frontiers in Nutrition
Teme:	autism spectrum disorder in children probiotics Bacteroides fragilis BF839 abnormal behavior gastrointestinal symptoms
Online dostop:	https://www.frontiersin.org/articles/10.3389/fnut.2024.1447059/full
Oznake:	Označite Brez oznak, prvi označite!